Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs

Journal article


Cornforth, Terri V., Moyo, Nathifa, Cole, Suzanne, Lam, Emily P. S., Lobry, Tatiana, Wolchinsky, Ron, Lloyd, Angharad, Ward, Katarzyna, Denham, Eleanor M., Masi, Giulia, Qing Yun, Phyllis Tea, Moore, Colin, Dhaouadi, Selsabil, Besra, Gurdyal S., Veerapen, Natacha, Illing, Patricia T., Vivian, Julian P., Raynes, Jeremy M., Le Nours, Jérôme, ... Dukes, Joseph. (2024). Conserved allomorphs of MR1 drive the specificity of MR1-restricted TCRs. Frontiers in Oncology. 14, p. Article 1419528. https://doi.org/10.3389/fonc.2024.1419528
AuthorsCornforth, Terri V., Moyo, Nathifa, Cole, Suzanne, Lam, Emily P. S., Lobry, Tatiana, Wolchinsky, Ron, Lloyd, Angharad, Ward, Katarzyna, Denham, Eleanor M., Masi, Giulia, Qing Yun, Phyllis Tea, Moore, Colin, Dhaouadi, Selsabil, Besra, Gurdyal S., Veerapen, Natacha, Illing, Patricia T., Vivian, Julian P., Raynes, Jeremy M., Le Nours, Jérôme, Purcell, Anthony W., Kundu, Samit, Silk, Jonathan D., Williams, Luke, Papa, Sophie, Rossjohn, Jamie, Howie, Duncan and Dukes, Joseph
Abstract

Background: Major histocompatibility complex class-1-related protein (MR1), unlike human leukocyte antigen (HLA) class-1, was until recently considered to be monomorphic. MR1 presents metabolites in the context of host responses to bacterial infection. MR1-restricted TCRs specific to tumor cells have been described, raising interest in their potential therapeutic application for cancer treatment. The diversity of MR1-ligand biology has broadened with the observation that single nucleotide variants (SNVs) exist within MR1 and that allelic variants can impact host immunity.

Methods: The TCR from a MR1-restricted T-cell clone, MC.7.G5, with reported cancer specificity and pan-cancer activity, was cloned and expressed in Jurkat E6.1 TCRαβ− β2M− CD8+ NF-κB:CFP NFAT:eGFP AP-1:mCherry cells or in human donor T cells. Functional activity of 7G5.TCR-T was demonstrated using cytotoxicity assays and by measuring cytokine release after co-culture with cancer cell lines with or without loading of previously described MR1 ligands. MR1 allele sequencing was undertaken after the amplification of the MR1 gene region by PCR. In vivo studies were undertaken at Labcorp Drug Development (Ann Arbor, MI, USA) or Epistem Ltd (Manchester, UK).

Results: The TCR cloned from MC.7.G5 retained MR1-restricted functional cytotoxicity as 7G5.TCR-T. However, activity was not pan-cancer, as initially reported with the clone MC.7.G5. Recognition was restricted to cells expressing a SNV of MR1 (MR1*04) and was not cancer-specific. 7G5.TCR-T and 7G5-like TCR-T cells reacted to both cancer and healthy cells endogenously expressing MR1*04 SNVs, which encode R9H and H17R substitutions. This allelic specificity could be overcome by expressing supraphysiological levels of the wild-type MR1 (MR1*01) in cell lines.

Conclusions: Healthy individuals harbor T cells reactive to MR1 variants displaying self-ligands expressed in cancer and benign tissues. Described “cancer-specific” MR1-restricted TCRs need further validation, covering conserved allomorphs of MR1. Ligands require identification to ensure targeting MR1 is restricted to those specific to cancer and not normal tissues. For the wider field of immunology and transplant biology, the observation that MR1*04 may behave as an alloantigen warrants further study. 

KeywordsMR1; alloreactive; T-cell; T-cell receptor (TCR); cancer
Year2024
JournalFrontiers in Oncology
Journal citation14, p. Article 1419528
PublisherFrontiers Media S.A.
ISSN2234-943X
Digital Object Identifier (DOI)https://doi.org/10.3389/fonc.2024.1419528
PubMed ID39445059
Scopus EID2-s2.0-85206971610
PubMed Central IDPMC11496959
Open accessPublished as ‘gold’ (paid) open access
Page range1-15
Publisher's version
License
File Access Level
Open
Output statusPublished
Publication dates
Online03 Oct 2024
Publication process dates
Accepted05 Aug 2024
Deposited01 Apr 2025
Additional information

© 2024 Cornforth, Moyo, Cole, Lam, Lobry, Wolchinsky, Lloyd, Ward, Denham, Masi, Qing Yun, Moore, Dhaouadi, Besra, Veerapen, Illing, Vivian, Raynes, Le Nours, Purcell, Kundu, Silk, Williams, Papa, Rossjohn, Howie and Dukes. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY) (http://creativecommons.org/licenses/by/4.0/). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

Permalink -

https://acuresearchbank.acu.edu.au/item/91886/conserved-allomorphs-of-mr1-drive-the-specificity-of-mr1-restricted-tcrs

Download files


Publisher's version
OA_Cornforth_2024_Conserved_allomorphs_of_MR1_drive_the.pdf
License: CC BY 4.0
File access level: Open

  • 1
    total views
  • 0
    total downloads
  • 1
    views this month
  • 0
    downloads this month
These values are for the period from 19th October 2020, when this repository was created.

Export as

Related outputs

An archaic HLA class I receptor allele diversifies natural killer cell-driven immunity in First Nations peoples of Oceania
Loh, Liyen, Saunders, Philippa M., Faoro, Camilla, Font-Porterias, Neus, Nemat-Gorgani, Neda, Harrison, Genelle F., Sadeeq, Suraju, Hensen, Luca, Wong, Shu Cheng, Widjaja, Jacqueline, Clemens, E. Bridie, Zhu, Shiying, Kichula, Katherine M., Tao, Sudan, Zhu, Faming, Montero-Martin, Gonzalo, Fernandez-Vina, Marcelo, Guethlein, Lisbeth A., Vivian, Julian P., ... Norman, Paul J.. (2024). An archaic HLA class I receptor allele diversifies natural killer cell-driven immunity in First Nations peoples of Oceania. Cell. 187(24), pp. 7008-7024. https://doi.org/10.1016/j.cell.2024.10.005
Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation
Jin, Dongbin, Loh, Khai Lee, Shamekhi, Tima, Ting, Yi Tian, Lim Kam Sian, Terry C. C., Roest, James, Ooi, Joshua D., Vivian, Julian Philip and Faridi, Pouya. (2023). Engineering Cell Lines for Specific Human Leukocyte Antigen Presentation. In In Jenkins, Brendan J. (Ed.). Inflammation and Cancer : Methods and Protocols pp. 351-369 Springer - Humana Press. https://doi.org/10.1007/978-1-0716-3331-1_25
Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection
Ullah, Tomalika R., Johansen, Matt D., Balka, Katherine R., Ambrose, Rebecca L., Gearing, Linden J., Roest, James, Vivian, Julian Philip, Sapkota, Sunil, Jayasekara, W. Samantha N., Wenholz, Daniel S., Aldilla, Vina R., Zeng, Jun, Miemczyk, Stefan, Nguyen, Duc H. and et. al.. (2023). Pharmacological inhibition of TBK1/IKKε blunts immunopathology in a murine model of SARS-CoV-2 infection. Nature Communications. 14(1), pp. 1-13. https://doi.org/10.1038/s41467-023-41381-9
Characterization of Monoclonal Antibodies to Measure Cell Surface Protein Levels of Human Interferon-Lambda Receptor 1
de Weerd, Nicole A., Ogungbola, Olamide, Liu, Xinyun, Matthews, Antony Y., Ismail, Amina, Vivian, Julian Philip, Lim, San S., Tyrrell, D. Lorne, Putcha, Niru, Skawinski, Mike, Dickensheets, Harold, Lavoie, Thomas B., Donnelly, Raymond P., Hertzog, Paul J. and Santer, Deanna M.. (2023). Characterization of Monoclonal Antibodies to Measure Cell Surface Protein Levels of Human Interferon-Lambda Receptor 1. Journal of Interferon and Cytokine Research. 43(9), pp. 403-413. https://doi.org/10.1089/jir.2023.0040
Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells
Palmer, William H., Leaton, Laura Ann, Codo, Ana Campos, Crute, Bergren, Roest, James, Zhu, Shiying, Petersen, Jan, Tobin, Richard P., Hume, Patrick S., Stone, Matthew, van Bokhoven, Adrie, Gerich, Mark E., McCarter, Martin D., Zhu, Yuwen, Janssen, William J., Vivian, Julian Philip, Trowsdale, John, Getahun, Andrew, Rossjohn, Jamie, ... Norman, Paul J.. (2023). Polymorphic KIR3DL3 expression modulates tissue-resident and innate-like T cells. Science Immunology. 8(84), pp. 1-18. https://doi.org/10.1126/sciimmunol.ade5343
The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-naïve healthy donors
Mifsud, Nicole A., Illing, Patricia T., Ho, Rebecca, Tuomisto, Johanna E., Fettke, Heidi, Mullan, Kerry A., McCluskey, James, Rossjohn, Jamie, Vivian, Julian Philip, Reantragoon, Rangsima and Purcell, Anthony W.. (2023). The allopurinol metabolite, oxypurinol, drives oligoclonal expansions of drug-reactive T cells in resolved hypersensitivity cases and drug-naïve healthy donors. Allergy. 78(11), pp. 2980-2993. https://doi.org/10.1111/all.15814
Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C
Moradi, Shoeib, Stankovic, Sanda, O’Connor, Geraldine M., Pymm, Phillip, MacLachlan, Bruce J., Faoro, Camilla, Retière, Christelle, Sullivan, Lucy C., Saunders, Philippa M., Widjaja, Jacqueline, Cox-Livingstone, Shea, Rossjohn, Jamie, Brooks, Andrew G. and Vivian, Julian P.. (2021). Structural plasticity of KIR2DL2 and KIR2DL3 enables altered docking geometries atop HLA-C. Nature Communications. 12(1), p. Article 2173. https://doi.org/10.1038/s41467-021-22359-x
Growth hormone stops excessive inflammation after partial hepatectomy, allowing liver regeneration and survival through induction of H2-Bl/HLA-G
Ishikawa, Mayumi, Brooks, Andrew J., Fernández-Rojo, Manuel A., Medina, Johan, Chhabra, Yash, Minami, Shiro, Tunny, Kathryn A., Parton, Robert G., Vivian, Julian Philip, Rossjohn, Jamie, Chikani, Viral, Ramm, Grant A., Ho, Ken K.Y. and Waters, Michael J.. (2021). Growth hormone stops excessive inflammation after partial hepatectomy, allowing liver regeneration and survival through induction of H2-Bl/HLA-G. Hepatology. 73(2), pp. 759-775. https://doi.org/10.1002/hep.31297
The role of the HLA Class I α2 Helix in determining ligand hierarchy for the killer cell Ig-like Receptor 3DL1
Saunders, Philippa M., MacLachlan, Bruce J., Widjaja, Jacqueline, Wong, Shu Cheng, Oates, Clare V. L., Rossjohn, Jamie, Vivian, Julian P. and Brooks, Andrew G.. (2021). The role of the HLA Class I α2 Helix in determining ligand hierarchy for the killer cell Ig-like Receptor 3DL1. Journal of Immunology. 206(4), pp. 849-860. https://doi.org/10.4049/jimmunol.2001109
Carbamazepine induces focused T cell responses in resolved Stevens-Johnson syndrome and toxic epidermal necrolysis cases but does not perturb the immunopeptidome for T cell recognition
Mifsud, Nicole A., Illing, Patricia T., Lai, Jeffrey W., Fettke, Heidi, Hensen, Luca, Huang, Ziyi, Rossjohn, Jamie, Vivian, Julian Philip, Kwan, Patrick and Purcell, Anthony W.. (2021). Carbamazepine induces focused T cell responses in resolved Stevens-Johnson syndrome and toxic epidermal necrolysis cases but does not perturb the immunopeptidome for T cell recognition. Frontiers in Immunology. 12, p. Article 653710. https://doi.org/10.3389/fimmu.2021.653710
A pocket guide on how to structure SARS-CoV-2 drugs and therapies
Littler, Dene R., MacLachlan, Bruce J., Watson, Gabrielle M., Vivian, Julian Philip and Gully, Benjamin S.. (2020). A pocket guide on how to structure SARS-CoV-2 drugs and therapies. Biochemical Society Transactions. 48(6), pp. 2625-2641. https://doi.org/10.1042/BST20200396
Structural integrity with functional plasticity : What type I IFN receptor polymorphisms reveal
de Weerd, Nicole A., Vivian, Julian P., Lim, San S., Huang, Stephanie U-Shane and Hertzog, Paul J.. (2020). Structural integrity with functional plasticity : What type I IFN receptor polymorphisms reveal. Journal of Leukocyte Biology. 108(3), pp. 909-924. https://doi.org/10.1002/JLB.2MR0420-152R
The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function
Saunders, Philippa M., MacLachlan, Bruce J., Pymm, Phillip, Illing, Patricia T., Deng, Yuanchen, Wong, Shu Cheng, Oates, Clare V. L., Purcell, Anthony W., Rossjohn, Jamie, Vivian, Julian P. and Brooks, Andrew G.. (2020). The molecular basis of how buried human leukocyte antigen polymorphism modulates natural killer cell function. Proceedings of the National Academy of Sciences of the United States of America. 117(21), pp. 11636-11647. https://doi.org/10.1073/pnas.1920570117
Downregulation of MHC class I expression by influenza A and B viruses
Koutsakos, Marios, McWilliam, Hamish E.G., Aktepe, Turgut E., Fritzlar, Svenja, Illing, Patricia T., Mifsud, Nicole A., Purcell, Anthony W., Rockman, Steve, Reading, Patrick C., Vivian, Julian P., Rossjohn, Jamie, Brooks, Andrew G., Mackenzie, Jason M., Mintern, Justine D., Villadangos, Jose A., Nguyen, Thi H. O. and Kedzierska, Katherine. (2019). Downregulation of MHC class I expression by influenza A and B viruses. Frontiers in Immunology. 10, p. Article 1158. https://doi.org/10.3389/fimmu.2019.01158
Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1
Martin, Maureen P., Naranbhai, Vivek, Shea, Patrick R., Qi, Ying, Ramsuran, Veron, Vince, Nicolas, Gao, Xiaojiang, Thomas, Rasmi, Brumme, Zabrina L., Carlson, Jonathan M., Wolinsky, Steven M., Goedert, James J., Walker, Bruce D., Segal, Florencia P., Deeks, Steven G., Haas, David W., Migueles, Stephen A., Connors, Mark, Michael, Nelson, ... Carrington, Mary. (2018). Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. Journal of Clinical Investigation. 128(5), pp. 1903-1912. https://doi.org/10.1172/JCI98463
HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome
Illing, Patricia T., Pymm, Phillip, Croft, Nathan P., Hilton, Hugo G., Jojic, Vladimir, Han, Alex S., Mendoza, Juan L., Mifsud, Nicole A., Dudek, Nadine L., McCluskey, James, Parham, Peter, Rossjohn, Jamie, Vivian, Julian P. and Purcell, Anthony W.. (2018). HLA-B57 micropolymorphism defines the sequence and conformational breadth of the immunopeptidome. Nature Communications. 9(1), p. Article 4693. https://doi.org/10.1038/s41467-018-07109-w
A subset of HLA-I peptides are not genomically templated : Evidence for cis- and trans-spliced peptide ligands
Faridi, Pouya, Li, Chen, Ramarathinam, Sri H., Vivian, Julian P., Illing, Patricia T., Mifsud, Nicole A., Ayala, Rochelle, Song, Jiangning, Gearing, Linden J., Hertzog, Paul J., Ternette, Nicola, Rossjohn, Jamie, Croft, Nathan P. and Purcell, Anthony W.. (2018). A subset of HLA-I peptides are not genomically templated : Evidence for cis- and trans-spliced peptide ligands. Science Immunology. 3(28), p. Article eaar3947. https://doi.org/10.1126/sciimmunol.aar3947